Aurinia Pharmaceuticals Inc. IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
Aurinia Pharmaceuticals Inc. | AUPH - |
Last Trade $16.66 |
$15.00 |
$0.00 | 13.33 million | 7/23/2020 |
Jefferies, SVB Leerink |
Co-Manager(s): |
|
Filing(s): |
For IPO Boutique's "scale of 1 to 5" BUY rating on Aurinia Pharmaceuticals Inc., and our comprehensive analysis, click "Buy Market Research".
Aurinia Pharmaceuticals Inc. Quote & Chart - Click for current quote -
AUPH
About Aurinia Pharmaceuticals Inc. (adapted from Aurinia Pharmaceuticals Inc. prospectus):
Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutic drugs for the treatment of various diseases in the United States and China.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "AUPH" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2024 IPO Boutique. All Rights Reserved